Life extension

American Academy of Anti-Aging Medicine (A4M) Announces First Keynote Speakers for the 29th Annual A4M World Congress in Las Vegas

Retrieved on: 
Tuesday, June 15, 2021
Articles, Demography, American Academy of Anti-Aging Medicine, Fringe science, Medical education in the United States, Pseudoscience, Medicine, Life extension, Mindfulness

The American Academy of Anti-Aging Medicine (A4M) the global leader for premium access to the latest innovations, breakthrough technologies and therapies in anti-aging and functional medicine is pleased to announced the first set of keynote speakers for the upcoming 29th Annual A4M World Congress taking place December 9-12, at the Ventian/Palazzo/Sands Resort in Las Vegas, NV.

Key Points: 
  • The American Academy of Anti-Aging Medicine (A4M) the global leader for premium access to the latest innovations, breakthrough technologies and therapies in anti-aging and functional medicine is pleased to announced the first set of keynote speakers for the upcoming 29th Annual A4M World Congress taking place December 9-12, at the Ventian/Palazzo/Sands Resort in Las Vegas, NV.
  • Jud Brewer, MD, PhD is a New York Times best-selling author, neuroscientist, addiction psychiatrist, and thought leader in the field of habit change.
  • He is the Director of Research and Innovation at Brown Universitys Mindfulness Center, where he also serves as an associate professor.
  • I am delighted to announce the focus on Brain Health in our upcoming World Congress, said Dr. Andrew Heyman, A4M Director of Academic Affairs.

"Super NMN" Officially Launched Under The Investment Of You Quanbing and His Team

Retrieved on: 
Thursday, May 20, 2021
Cosmetics, Retail, Health, Other Health, Demography, Ageing, Academic disciplines, Articles, Old age, Gerontology, Life extension, Population

b'Pengmen International recently announced that the "Super NMN" anti-aging product, led by You Quanbing and his team, will soon be officially launched on the market.\nThis press release features multimedia.

Key Points: 
  • b'Pengmen International recently announced that the "Super NMN" anti-aging product, led by You Quanbing and his team, will soon be officially launched on the market.\nThis press release features multimedia.
  • In some countries, the aging of the population has been lasting for a long time.
  • All of them are among the countries with the most severe population aging problem in the world.
  • \xe2\x80\x9cInvesting in health and human health is the cause I will never regret in my life!\xe2\x80\x9d\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519006048/en/\n'

Global Stem Cell Therapy Market Report 2021: COVID-19 Influences, Growth and Changes to 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 14, 2021
Biotechnology, Pharmaceutical, Health, Branches of biology, Life sciences, Biology, Stem cells, Biotechnology, Cell biology, Emerging technologies, Life extension, Stem-cell therapy, Cell therapy, Therapy

b'The "Stem Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com\'s offering.\nStem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global stem cell therapy market.\nMajor players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell.\nThe growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.\nThe stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy.

Key Points: 
  • b'The "Stem Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com\'s offering.\nStem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global stem cell therapy market.\nMajor players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell.\nThe growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.\nThe stem cell therapy market consists of the sales of stem cell therapy and related services by entities (organizations, sole traders, and partnerships) that provide stem cell therapy.
  • Only goods and services traded between entities or sold to end consumers are included.\nThe high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market.
  • Semma Therapeutics is a US-based company that is involved in using stem cell therapy for diabetes treatment.\nThe rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market.
  • The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.\nThe companies in the stem cell therapy market are increasingly investing in strategic partnerships.

GIOSTAR Chairman Receives Award for Outstanding Cancer Research from SAASCR

Retrieved on: 
Tuesday, May 4, 2021
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Life extension, Stem-cell therapy, American Association for Cancer Research, Canadian Stem Cell Foundation

b'SAN DIEGO, May 4, 2021 /PRNewswire/ -- Global Institute of Stem Cell Therapy and Research (GIOSTAR), the pioneer in the field of stem cell science and regenerative medicine, was recently recognized for innovation in cancer research.

Key Points: 
  • b'SAN DIEGO, May 4, 2021 /PRNewswire/ -- Global Institute of Stem Cell Therapy and Research (GIOSTAR), the pioneer in the field of stem cell science and regenerative medicine, was recently recognized for innovation in cancer research.
  • The Society of American Asian Scientists in Cancer Research (SAASCR) honored GIOSTAR Chairman and Co-Founder Dr. Anand Srivastava with their prestigious Outstanding Achievement Award for 2020.
  • The Chandigarh center is focused primarily on cancer research.\nSAASCR is a California-based non-profit organization boasting more than 5,000 members - all of whom also share membership in the American Association for Cancer Research.
  • Headquartered in San Diego, USA, GIOSTAR\'s team includes international leaders in the field of stem cell research, technologies, healthcare delivery, and hospital administration.\n'

Newest Breakthrough in Anti-aging Discovered

Retrieved on: 
Wednesday, April 28, 2021
Branches of biology, Nucleotides, Academic disciplines, Cellular respiration, Coenzymes, Photosynthesis, Ageing, Articles, Nicotinamide adenine dinucleotide, Life extension, NMN

As we age, the level of NAD+ decreases, and this decrease, which intensifies after the age of 30, is a principal trigger in the process of aging.

Key Points: 
  • As we age, the level of NAD+ decreases, and this decrease, which intensifies after the age of 30, is a principal trigger in the process of aging.
  • Thus, boosting NAD+ levels is the key to the fountain of youth: anti-aging.\nHowever, NAD+ is an unstable compound which renders it impractical as a direct supplement or injection.
  • FOUNT\'Y NMN 12000\'s effectiveness also does not diminish gradually in time, as is the case with other NMN supplement brands, due to its special proprietary formula of activators and blockers.
  • It has also received a Certificate of GMP issued by Consumer Health Products Canada.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/newest-breakthrough-in-anti-agin...\n'

Study Suggests the Pandemic May be Increasing Symptoms of Aging but Help is Available, says Revitalize Anti Aging Centers

Retrieved on: 
Wednesday, April 21, 2021
Branches of biology, Medicine, Clinical medicine, Menopause, Bioidentical hormone replacement therapy, Masculinizing hormone therapy, Feminizing hormone therapy, Hormone replacement therapy, Stress, Hormone, Life extension, Wiley protocol

The article explores how prolonged stress can have a physiological effect on a person's appearance and overall health, including causing more wrinkling of the skin, a slower metabolism, and fatigue.

Key Points: 
  • The article explores how prolonged stress can have a physiological effect on a person's appearance and overall health, including causing more wrinkling of the skin, a slower metabolism, and fatigue.
  • The anti-aging center says bioidentical hormone replacement therapy (BHRT) replenishes key hormones in the body to reverse some of the negative effects of aging and/or stress.
  • This means that the risk of side effects is reduced and the effectiveness of treatment may be increased.
  • They serve the Encino, Sherman Oaks, Beverly Hills, and Greater Los Angeles areas.\n"

Qihan Biotech Raises Additional USD 67 Million in Series A++ Financing

Retrieved on: 
Monday, March 29, 2021
Biotechnology, Other Health, Health, Genetics, Clinical trials, Branches of biology, Life sciences, Biology, Biotechnology, Animal testing, Life extension, Organ transplantation, Xenotransplantation, Cell therapy, Cellectis, Qihan Biotech, Lilly Asia Ventures

Qihan Biotechnology Co. Ltd (Qihan or the Company), a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that it has raised an additional $67 million in Series A++ financing.

Key Points: 
  • Qihan Biotechnology Co. Ltd (Qihan or the Company), a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that it has raised an additional $67 million in Series A++ financing.
  • With these investments, Qihans total Series A financing raised to date has exceeded $100 million.
  • Considering the long research period and difficulty of xenotransplantation products, Qihan may commercialize cell therapy products prior to xenotransplantation.
  • Qihan Biotech is a biotechnology company applying genome-editing technology to develop novel cell therapies and organs for transplantation.

Life Extension Launches Senolytic Activator®

Retrieved on: 
Tuesday, March 23, 2021
Branches of biology, Articles, Biology, Old age, Diets, Senescence, Senolytic, Fisetin, Life extension, MTOR, Gluten-free diet, Gluten

Fort Lauderdale, FL, March 23, 2021 (GLOBE NEWSWIRE) -- To help the body manage cells that no longer function optimally, Life Extension has launched Senolytic Activator .

Key Points: 
  • Fort Lauderdale, FL, March 23, 2021 (GLOBE NEWSWIRE) -- To help the body manage cells that no longer function optimally, Life Extension has launched Senolytic Activator .
  • "We updated our Senolytic Activator by adding an advanced form of bioavailable fisetin that we discovered and developed in collaboration with scientists at Akay," said Dr. Andrew G. Swick, Life Extension's Chief Scientific Officer.
  • According to Dr. Swick, thats why Life Extension added potent antioxidant apigenin, which works by targeting any remaining senescent cells and supporting cellular and tissue health, a critical aspect of healthy aging.
  • Life Extensions Senolytic Activator comes in easy-to-swallow, gluten-free, vegetarian capsules.

Graystone Company Completes Formulation of its Nano-Delivery of the Fucoidan Longevity Booster

Retrieved on: 
Tuesday, March 16, 2021
Population, Articles, Brown algae, Fucoidan, Polysaccharides, Academic disciplines, Ageing, Longevity, Life extension, Time

FORT LAUDERDALE, Fla., March 16, 2021 /PRNewswire/ --Graystone Company, Inc. (OTC: GYST) announced today the completion of the formulation of one of its signature products, Fucoidan Longevity Booster, the flagship product for its Immune Support, Anti-Inflammatory & Anti-Aging Product Line.

Key Points: 
  • FORT LAUDERDALE, Fla., March 16, 2021 /PRNewswire/ --Graystone Company, Inc. (OTC: GYST) announced today the completion of the formulation of one of its signature products, Fucoidan Longevity Booster, the flagship product for its Immune Support, Anti-Inflammatory & Anti-Aging Product Line.
  • The Fucoidan Longevity Booster represents the initial product in the expected line of products that will address immune support, anti-inflammatory and anti-aging.
  • It has also been shown that fucoidan has the potential to boost important anti-viral, anti-tumor and anti-aging responses.
  • Graystone has been committed to delivering the only capsulized nano-formulation that will improve the absorption and effectiveness of the Fucoidan.

Anti-Aging Market Revenue Worth $421.4 Billion by 2030: P&S Intelligence

Retrieved on: 
Monday, March 15, 2021
Ageing, Emerging technologies, Articles, Life extension, Population, Transhumanism, Time, Academic disciplines

During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.

Key Points: 
  • During the five sessions of the conference, opinion leaders and industry experts shared knowledge and had discussions regarding anti-aging and aesthetics.
  • Due to the rising number of such conferences and seminars, the global anti-aging market is set to experience an 8.1% CAGR during 20202030, to grow from $191.5 billion in 2019 to $421.4 billion by 2030, according to P&S Intelligence.
  • This is because such events generally involve the launch and promotion of an array of devices and products by cosmetic and personal care companies.
  • Therefore, the anti-aging market is primarily advancing due to the rising awareness of consumers about the latest associated products available and under development.